Swiss Life Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Swiss Life Asset Management's EXAS Position: Q1 2026 in Review
Swiss Life Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,027 shares — an estimated $917K sold.
Swiss Life Asset Management first reported a position in EXAS in Q2 2022 and held it in 11 quarters. The position peaked at $4.17M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Swiss Life Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Swiss Life Asset Management sold 9,027 Exact Sciences shares in Q1 2026, an estimated $917K.
- Swiss Life Asset Management first reported a position in Exact Sciences in Q2 2022 and held it in 11 quarters.
- Swiss Life Asset Management's Exact Sciences position peaked at $4.17M in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Swiss Life Asset Management's 13F filing for Q1 2026, filed 14 May 2026.